This episode currently has no reviews.
Submit ReviewModerna has now become the second company to request emergency use authorization from the FDA for their vaccine candidate. In their latest findings, the vaccine is over 94% effective against coronavirus and very effective at preventing serious cases of the virus. The next step will be on Dec. 10 when the FDA will discuss approval for Pfizer and then Dec. 17 for Moderna. Karen Weintraub, health reporter at USA Today, joins us for more as we get closer to vaccine approvals.
Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
See omnystudio.com/listener for privacy information.
This episode currently has no reviews.
Submit ReviewThis episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review